Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Countries

 

Amedes for sale as Synlab forecasts future organic growth to settle about 3%

Europe's largest lab group Synlab forecasts that it will see 3+% of annual organic growth over the mid-term, saying that testing will remain a core part of pandemic control. Other lab groups clearly agree with that punt, with news that smaller rival Amedes reportedly is preparing for sale.
February 25, 2021

Bergman buys German cosmetic group

Netherlands-based ambulatory and ophthalmology clinic group Bergman Clinics, currently exploring a sale that could raise over €1bn, has acquired German aesthetic surgical treatments platform Medical One.
February 25, 2021

The evidence needed for health apps is changing

The quick rise of health apps has meant processes for approval and reimbursement have largely replicated ones for bringing new drugs to market. That is now starting to change, with many of the new reimbursement schemes recognising a need for real-world evidence over randomised clinical trials and new standards being created specifically for apps.
February 25, 2021

Carlyle to exit Ameos in H2

Private equity firm Carlyle will exit German and Swiss acute/psychiatric hospital operator Ameos Group in the second half of this year, a spokesperson for Ameos tells HBI. Reports say that CEO Dr Axel Paeger and London-listed Intermediate Capital Group (ICG) will become controlling shareholders.
February 22, 2021

FREE BLOG Governments are already tired of how much telehealth costs

Telehealth had reached a critical mass in Sweden with providers able to generate decent sales from an established reimbursement model. However, spiralling costs have now tipped its payors over the edge with many refusing to pay the tariff. It's not the first time that authorities have taken a stand against telehealth's costs and it could have far-reaching policy implications.
February 18, 2021

Ameos sale/refinancing: Speculation mounts as group denies discussions

Despite emphatic denials from the company itself that it is for sale, multiple sources continue to tell HBI that DACH psychiatry and acute hospital group Ameos is in discussion with potential suitors and that documentation preparing for refinancing and/or sale has been drawn up. HBI speaks to an operator source, a consultant, and the company to find out more.
February 18, 2021

Swedish regions vow to stop paying for telehealth

A quarter of Swedish regions, home to more than a quarter of all Swedes, have signalled that they will stop paying millions of euros to the country's for-profit telehealth suppliers like Kry.
February 18, 2021

McDermott Will & Emery talks Europe’s complex regulatory landscape

Encroaching protectionism from governments across Europe is leading to some initiatives that might limit foreign investment in key strategic services like healthcare. Sharon Lamb, a partner with law firm MWE, talks to HBI about those new laws and a host of others introduced over the last year. It’s a complex regulatory and reimbursement landscape but MWE has a new report to help. 
February 18, 2021
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us